Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Patent Publication Number 20210261622
US 20210261622 A1Patent NumberUS 11845808 B2
Application Number17149509
Filled DateJan 14, 2021
Priority DateJan 15, 2020
Publication DateAug 26, 2021
Original AssigneeJohnson & Johnson
Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc.
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsBrian Troy Frederick
Elisabetta Bianchi
Raymond Patch
Chengzao Sun
Raffaele Ingenito
Gregory Thomas Bourne
Ashok Bhandari
Roberto Costante
Danila Branca
Sandeep Somani
Elisabetta Bianchi
Raymond Patch
Chengzao Sun
Raffaele Ingenito
Gregory Thomas Bourne
Ashok Bhandari
Roberto Costante
Danila Branca
Sandeep Somani
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.